This regulatory action marks the first time a genetically modified cell therapy has been approved for a solid tumor cancer in the United States.
FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adult Patients with Synovial Sarcoma Who Have Been Treated with Chemotherapy
Leave a comment
